Rigel Pharmaceuticals (RIGL) Net Margin (2010 - 2026)
Rigel Pharmaceuticals' quarterly Net Margin came in at 14.71% in Q1 2026, down 675.0% year-on-year from 2.56% in Q1 2025, and down 96.17% quarter-over-quarter from 384.04% in Q4 2025.
Rigel Pharmaceuticals has reported Net Margin for 16 years, with the latest figure at 14.71% in Q1 2026.
- For the quarter ending Q1 2026, Net Margin fell 675.0% year-over-year to 14.71%; the trailing twelve-month figure through Mar 2026 stood at 121.51% (up 10320.0% YoY), and the FY2025 full-year result was 124.72%, up 11497.0% from the prior year.
- Net Margin for Q1 2026 stood at 14.71%, down from 384.04% in the prior quarter.
- The five-year high for Net Margin was 384.04% in Q4 2025, with the low at 164.0% in Q1 2022.
- Average Net Margin over 5 years is 8.8%, with a median of 2.06% recorded in 2023.
- Year-over-year, Net Margin tumbled 21275 bps in 2022 and jumped 35914 bps in 2025.
- Tracing RIGL's Net Margin over 5 years: stood at 2.73% in 2022, then fell by 25 bps to 2.06% in 2023, then soared by 1109 bps to 24.9% in 2024, then jumped by 1442 bps to 384.04% in 2025, then tumbled by 96 bps to 14.71% in 2026.
- The last three Net Margin figures came in at 14.71% (Q1 2026), 384.04% (Q4 2025), and 40.17% (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 0.82% |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 34.53% |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 20.17% |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 17.65% |
| 10 | Rigel Pharmaceuticals | 551.62 Mn | 404.94 Mn | 54.21 Mn | 14.71% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 14.71% |
| Dec 31, 2025 | 384.04% |
| Sep 30, 2025 | 40.17% |
| Jun 30, 2025 | 58.63% |
| Mar 31, 2025 | 21.46% |
| Dec 31, 2024 | 24.90% |
| Sep 30, 2024 | 22.46% |
| Jun 30, 2024 | -2.80% |
| Mar 31, 2024 | -27.92% |
| Dec 31, 2023 | 2.06% |
| Sep 30, 2023 | -20.23% |
| Jun 30, 2023 | -24.55% |
| Mar 31, 2023 | -51.92% |
| Dec 31, 2022 | 2.73% |
| Sep 30, 2022 | -84.95% |
| Jun 30, 2022 | -45.25% |
| Mar 31, 2022 | -164.00% |
| Dec 31, 2021 | -110.74% |
| Sep 30, 2021 | -97.26% |
| Jun 30, 2021 | -52.62% |
| Mar 31, 2021 | 48.75% |
| Dec 31, 2020 | -104.27% |
| Sep 30, 2020 | -77.08% |
| Jun 30, 2020 | -109.71% |
| Mar 31, 2020 | 38.10% |
| Dec 31, 2019 | -111.69% |
| Sep 30, 2019 | -55.09% |
| Jun 30, 2019 | -198.00% |
| Mar 31, 2019 | -139.40% |
| Dec 31, 2018 | 8.53% |
| Sep 30, 2018 | -488.51% |
| Jun 30, 2018 | -1,430.16% |
| Dec 31, 2017 | 576.96% |
| Sep 30, 2017 | -1,962.22% |
| Mar 31, 2017 | -427.29% |
| Dec 31, 2016 | -519.67% |
| Sep 30, 2016 | -601.84% |
| Jun 30, 2016 | -157.47% |
| Mar 31, 2016 | -347.27% |
| Dec 31, 2015 | -148.61% |
| Sep 30, 2015 | -51.34% |
| Jun 30, 2015 | -268.36% |
| Mar 31, 2015 | -835.31% |
| Dec 31, 2013 | -293.23% |
| Jun 30, 2013 | -1,626.29% |
| Jun 30, 2012 | -1,649.20% |
| Mar 31, 2012 | -3,089.87% |
| Sep 30, 2011 | -411.73% |
| Jun 30, 2011 | -5,436.46% |
| Sep 30, 2010 | 69.77% |
| Jun 30, 2010 | 54.65% |